银屑病临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 银屑病（国际通用名 psoriasis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖牛皮癣、银屑病关节炎等说法。

正在招募的银屑病新药试验

• Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

  不适用招募中英国NCT07166315

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

  II 期招募中美国加拿大德国PolandNCT07013201

• Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

  II 期招募中中国NCT07251998

• Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis

  不适用招募中NorwayNCT05291819

• Real-Life Evaluation of Guselkumab Dosing Interval Adjustments

  不适用招募中法国NCT07430319

• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

  不适用招募中法国NCT06599411

• Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

  III 期招募中中国NCT07130604

• Psoriatic Immune Response to Tildrakizumab

  IV 期招募中美国NCT05390515

• Influence of Sodium Intake in spondyLoarthriTes

  不适用招募中法国NCT06259890

• Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

  不适用招募中美国NCT07180537

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

  I 期招募中美国NCT07024602

• The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

  IV 期招募中美国NCT07487831